145 related articles for article (PubMed ID: 8677658)
1. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
[TBL] [Abstract][Full Text] [Related]
2. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
3. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
4. Influence of intravascular molecular weight of hydroxyethyl starch on platelets.
Treib J; Haass A; Pindur G; Treib W; Wenzel E; Schimrigk K
Eur J Haematol; 1996 Mar; 56(3):168-72. PubMed ID: 8598237
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):71-8. PubMed ID: 19527967
[TBL] [Abstract][Full Text] [Related]
6. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
7. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
8. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
9. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
Jung F; Waldhausen P; Spitzer S; Wenzel E
Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
[TBL] [Abstract][Full Text] [Related]
10. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
Jones PA; Tomasic M; Gentry PA
Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
[TBL] [Abstract][Full Text] [Related]
11. [Changes in blood coagulation in treatment with hydroxyethyl starch].
Sefrin P; Rauch S; Zieglmeyer C
Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
[TBL] [Abstract][Full Text] [Related]
12. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
13. Coagulation disorders caused by hydroxyethyl starch.
Treib J; Haass A; Pindur G
Thromb Haemost; 1997 Sep; 78(3):974-83. PubMed ID: 9308738
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
Thaler U; Deusch E; Kozek-Langenecker SA
Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
[TBL] [Abstract][Full Text] [Related]
15. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
16. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein.
Chen G; Yan M; Lu QH; Gong M
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1089-94. PubMed ID: 16987338
[TBL] [Abstract][Full Text] [Related]
17. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J
Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130
[TBL] [Abstract][Full Text] [Related]
18. [Blood volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
20. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]